Assertio Holdings (ASRT) Total Liabilities (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Total Liabilities came in at $135.7 million in Q1 2026, down 23.74% year-on-year from $177.9 million in Q1 2025, and down 21.59% quarter-over-quarter from $173.0 million in Q4 2025.
Assertio Holdings (ASRT) Total Liabilities (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Total Liabilities across 8 years of filings, most recently posting $135.7 million for Q1 2026.
- Total Liabilities for Q1 2026 came in at $135.7 million, down 23.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $135.7 million (down 23.74% YoY), and the FY2025 annual result was $173.0 million, up 5.72% from the prior year.
- Total Liabilities came in at $135.7 million for Q1 2026 at Assertio Holdings, down from $173.0 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $227.3 million in Q1 2022 to a low of $135.7 million in Q1 2026.
- The 5-year median for Total Liabilities is $173.0 million (2025), against an average of $172.5 million.
- Across the five-year window, Total Liabilities retreated 28.01% in 2023 and jumped 47.08% in 2025, its largest moves.
- Assertio Holdings' Total Liabilities stood at $188.2 million in 2022, then dropped by 21.13% to $148.4 million in 2023, then gained by 10.27% to $163.7 million in 2024, then rose by 5.72% to $173.0 million in 2025, then fell by 21.59% to $135.7 million in 2026.
- The last three Total Liabilities figures came in at $135.7 million (Q1 2026), $173.0 million (Q4 2025), and $214.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 31.81 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.92 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 813.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 148.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.50 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.72 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.51 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.82 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | 135.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 135.67 Mn |
| Dec 31, 2025 | 173.02 Mn |
| Sep 30, 2025 | 213.97 Mn |
| Jun 30, 2025 | 180.48 Mn |
| Mar 31, 2025 | 177.90 Mn |
| Dec 31, 2024 | 163.65 Mn |
| Sep 30, 2024 | 145.48 Mn |
| Jun 30, 2024 | 147.29 Mn |
| Mar 31, 2024 | 147.47 Mn |
| Dec 31, 2023 | 148.42 Mn |
| Sep 30, 2023 | 187.16 Mn |
| Jun 30, 2023 | 150.91 Mn |
| Mar 31, 2023 | 163.61 Mn |
| Dec 31, 2022 | 188.19 Mn |
| Sep 30, 2022 | 188.43 Mn |
| Jun 30, 2022 | 193.61 Mn |
| Mar 31, 2022 | 227.27 Mn |
| Dec 31, 2021 | 224.13 Mn |
| Sep 30, 2021 | 202.45 Mn |
| Jun 30, 2021 | 219.75 Mn |